<?xml version="1.0" encoding="UTF-8"?>
<ref id="feb213806-bib-0017">
 <label>17</label>
 <mixed-citation publication-type="journal" id="feb213806-cit-0017">
  <string-name>
   <surname>Xu</surname>
   <given-names>Z</given-names>
  </string-name>, 
  <string-name>
   <surname>Peng</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Shi</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhu</surname>
   <given-names>Z</given-names>
  </string-name>, 
  <string-name>
   <surname>Mu</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>
   <given-names>X</given-names>
  </string-name> and 
  <string-name>
   <surname>Zhu</surname>
   <given-names>W</given-names>
  </string-name>. (
  <year>2020</year>) 
  <article-title>Nelfinavir was predicted to be a potential inhibitor of 2019‚ÄênCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation</article-title>. 
  <source xml:lang="en">biorxiv</source>, 2020.01.27.921627 [PREPRINT].
 </mixed-citation>
</ref>
